In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Drug:  nimotuzumab
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2010ESO_FU, NCT01402180
2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 to 70
Sponsor: Other
Protocol IDs: IHN01, NCT00957086
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: BT-CT-001, NCT01074021
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DE766-A-J302, NCT01813253
5.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 to 70
Sponsor: Other
Protocol IDs: IB/NCCS-01, NCT00702481
6.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: BT-CRC-T, NCT00972465
7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: BT-IST-NSCLC-010, NCT00983047
8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 3 to 18
Sponsor: Other
Protocol IDs: EF090, NCT01145170
9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CH-GI-010, NCT01180166
10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: BT-ESO-1001, NCT01232374
11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: N+TP-AEC3, NCT01336049
12.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EF 118, NCT01345084
13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: BT-IST-SCCHN-008, NCT01425736
14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: 4-2011-0662, NCT01498562
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: N+FOLFIRI-AEC-4, NCT01486992
16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BT-IST-SCCHN-036, NCT01516996
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: PF-N-UMNPC, NCT01616849
18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: NimoESCC, NCT01688700
19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: BT-ESO-T-0901, NCT00950417
20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: BT-NSCLC-T-0902, NCT00985998
21.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BT-IST-NSCLC-053, NCT01393080
New Search